Compare ALKS & FBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALKS | FBP |
|---|---|---|
| Founded | 1987 | 1948 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 3.6B |
| IPO Year | 2012 | 2010 |
| Metric | ALKS | FBP |
|---|---|---|
| Price | $29.74 | $21.18 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 4 |
| Target Price | ★ $43.29 | $24.13 |
| AVG Volume (30 Days) | ★ 2.0M | 1.4M |
| Earning Date | 04-30-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 3.80% |
| EPS Growth | N/A | ★ 18.78 |
| EPS | 1.43 | ★ 2.15 |
| Revenue | ★ $1,475,899,000.00 | $1,255,034,000.00 |
| Revenue This Year | $24.26 | $15.10 |
| Revenue Next Year | $4.63 | $4.56 |
| P/E Ratio | $20.53 | ★ $9.80 |
| Revenue Growth | N/A | ★ 2.38 |
| 52 Week Low | $25.17 | $16.40 |
| 52 Week High | $36.32 | $23.43 |
| Indicator | ALKS | FBP |
|---|---|---|
| Relative Strength Index (RSI) | 53.62 | 51.46 |
| Support Level | $27.48 | $20.41 |
| Resistance Level | $30.36 | $22.28 |
| Average True Range (ATR) | 0.91 | 0.54 |
| MACD | 0.31 | 0.10 |
| Stochastic Oscillator | 90.22 | 91.94 |
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
First BanCorp is a financial holding company. The company's operating segment includes Commercial and Corporate Banking; Mortgage Banking; Consumer (Retail) Banking; Treasury and Investments; United States Operations; and Virgin Islands Operations. It generates maximum revenue from the Consumer (Retail) Banking segment. The Consumer (Retail) Banking segment generates majority revenue, which consists of the Corporation's consumer lending and deposit-taking activities conducted mainly through its branch network and loan centres. Geographically, it derives a majority of revenue from Puerto Rico.